May 4, 2022

  • Uncategorized

Gynecologic cancer care now offered at Cancer Partners of Nebraska

Cancer Partners of Nebraska has Lincoln’s first gynecologic oncology surgeon on staff. Peter Morris, MD, offers gynecologic cancer treatments that haven’t previously been available in the city.

Keep reading

March 2, 2022

  • Uncategorized

Reduce Hair Loss During Chemotherapy

We are excited to offer our patients a new approach to reduce chemotherapy-induced hair loss. Recently, Dr. Joni Tilford discussed the scalp cooling treatment with Channel 10/11 News.

Keep reading

January 18, 2022

  • Uncategorized

Cancer Partners of Nebraska Brings New Cancer Specialty to Lincoln

Cancer Partners is excited to bring a new specialty, gynecologic oncology surgery, to the women of Lincoln. 1011 News interviewed our gynecological oncology surgeon, Dr. Peter Morris, and one of our patients recently to discuss what this means to our community.

Keep reading

January 6, 2022

  • Uncategorized

Heart to Hold Project Offers Comfort to Cancer Patients

Dr. Mark Stavas was interviewed recently about our Hearts to Hold project. In collaboration with TeamMates Mentoring Program, we are able to give these hearts to our patients.

Keep reading

January 3, 2022

  • Uncategorized

Cancer Partners Adds Peter Morris, MD and New Specialty

Cancer Partners of Nebraska is pleased to announce Peter Morris, MD has joined their growing team of cancer specialists. Dr. Morris will be Lincoln’s first gynecologic oncology surgeon and will be adding a much-needed service (gynecologic oncology) to the greater Lincoln area.

Keep reading

December 6, 2021

  • Uncategorized

Dr. Green Co-Authored Manuscript for Journal of Geriatric Oncology

The purpose of this study was to evaluate expected side effects from chemoradiation (CRT) as an important factor in treatment decisions in older adults with rectal and anal cancers. The objective was to compare side effects of older and younger adults with rectal and anal cancers treated on NRG Oncology studies. The results of this study showed older patients with these cancers undergoing CRT were less likely to complete chemotherapy and had worse side effects. Physicians can now use these results to counsel older adults prior to treatment and manage expected side effects throughout pelvic CRT.

Keep reading
To Top